Palliative chemotherapy and targeted therapies for esophageal and gastroesophageal junction cancer-Reference-Cited by-同舟云学术

Palliative chemotherapy and targeted therapies for esophageal and gastroesophageal junction cancer

Published:2017-11-28 Issue:11 Volume:2017 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Janmaat Vincent T¹,Steyerberg Ewout W²,van der Gaast Ate³,Mathijssen Ron HJ³,Bruno Marco J¹,Peppelenbosch Maikel P¹,Kuipers Ernst J¹,Spaander Manon CW¹

Affiliation:

1. Erasmus University Medical Center; Department of Gastroenterology and Hepatology; Rotterdam Netherlands

2. Erasmus University Medical Center; Department of Public Health; PO Box 2040 Rotterdam Netherlands 3000 CA

3. Erasmus MC Cancer Institute, Erasmus University Medical Center; Department of Medical Oncology; Dr. Molewaterplein 40 Rotterdam Netherlands 3015 GD

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004063.pub4/epdf/full

Reference259 articles.

1. Phase II multi-institutional randomized trial of docetaxel plus cisplatin with or without fluorouracil in patients with untreated, advanced gastric, or gastroesophageal adenocarcinoma;Ajani;Journal of Clinical Oncology,2005

2. Combination of cisplatin/S-1 in the treatment of patients with advanced gastric or gastroesophageal adenocarcinoma: results of noninferiority and safety analyses compared with cisplatin/5-fluorouracil in the First-Line Advanced Gastric Cancer Study;Ajani;European Journal of Cancer,2013

3. Multicenter phase III comparison of cisplatin/S-1 with cisplatin/infusional fluorouracil in advanced gastric or gastroesophageal adenocarcinoma study: the FLAGS trial;Ajani;Journal of Clinical Oncology,2010

4. Clinical benefit and health-related quality of life assessment in patients treated with cisplatin/S-1 versus Cisplatin/5-FU: secondary end point results from the first-line advanced gastric cancer study (FLAGS);Bodoky;Journal of Gastrointestinal Cancer,2015

5. Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin: a study of the Arbeitsgemeinschaft Internistische Onkologie;Al-Batran;Journal of Clinical Oncology,2008

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phase III randomized trial comparing palliative systemic therapy to best supportive care in advanced esophageal/GEJ cancer;International Journal of Cancer;2024-08-02

2. Interval Metastases After Neoadjuvant Chemoradiotherapy for Patients with Locally Advanced Esophageal Cancer: A Multicenter Observational Cohort Study;Annals of Surgical Oncology;2024-07-27

3. Utilising systematic reviews to assess potential overtreatment and claim for better evidence-based research: an analysis of anticancer drugs versus supportive care in advanced esophageal cancer;Systematic Reviews;2024-07-18

4. Gastro-Esophageal Cancer: Can Radiomic Parameters from Baseline 18F-FDG-PET/CT Predict the Development of Distant Metastatic Disease?;Diagnostics;2024-06-06

5. Advances in diagnosis and management of cancer of the esophagus;BMJ;2024-06-03